Immatics
Price & Volume
Stats
See more52W Range | $3.30-$12.41 |
Market Cap | $1.3B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $48.2M |
Revenue Growth (YoY) | -64.9% |
Gross Profit (12 Mos) | -$135.5M |
Diluted EPS | -$1.87 |
News
See moreYahoo Finance • 15 days ago
Immatics N.V. (IMTX) Seeing Strong Enrollment in a Key Phase 3 Trial of Drug Candidate
Yahoo Finance • 4 months ago
Immatics Announces $125 Million Underwritten Offering
Yahoo Finance • 4 months ago
Immatics Achieves Clinical Proof-of-Concept of its Next-Generation TCR Bispecific (TCER®) Pipeline with Data on IMA402 (PRAME) and IMA401 (MAGEA4/8) and Announces Next Development Steps
Yahoo Finance • 6 months ago
Immatics appoints industry veteran as CFO
About
CEO | Dr. Harpreet Singh Ph.D. |
Address | Paul-Ehrlich-Strasse 15-19, Tübingen, Germany, 72076 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 589 |
